MedPath

Registry of breast cancer patients treated using proton therapy

Not Applicable
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Registration Number
CTRI/2020/11/029415
Lead Sponsor
Apollo Proton Cancer Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Histopathologically confirmed breast cancer patients being planned for proton therapy

2. Patients who have the ability to understand and be willing to sign a written informed consent document

Exclusion Criteria

1. Patients or legal guardians who are unable to understand informed consent document

2. Metastatic disease

3. Connective tissue disorders such as scleroderma, rheumatoid arthritis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath